Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(20%)
Results Posted
75%(6 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
5
33%
Ph not_applicable
2
13%
Ph phase_2
6
40%
Ph phase_4
1
7%

Phase Distribution

5

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
5(35.7%)
Phase 2Efficacy & side effects
6(42.9%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
2(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(3)

Detailed Status

Completed8
unknown3
Active, not recruiting2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (35.7%)
Phase 26 (42.9%)
Phase 41 (7.1%)
N/A2 (14.3%)

Trials by Status

completed853%
unknown320%
terminated17%
active_not_recruiting213%
recruiting17%

Recent Activity

3 active trials
Showing 5 of 15
terminatedphase_1

Recall by Genotype: Neuropeptide Stimulation

NCT05901467
active_not_recruitingnot_applicable

Reprometabolic Syndrome Mediates Subfertility in Obesity

NCT02653092
completedphase_2

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

NCT04648969
recruitingphase_4

GnRH for Luteal Support in IVF/ICSI/FET Cycles

NCT02357654
completedphase_2

Administration of Kisspeptin in Patients With Hyperprolactinemia

NCT02956447
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05901467Phase 1

Recall by Genotype: Neuropeptide Stimulation

Terminated
NCT02653092Not Applicable

Reprometabolic Syndrome Mediates Subfertility in Obesity

Active Not Recruiting
NCT04648969Phase 2

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

Completed
NCT02357654Phase 4

GnRH for Luteal Support in IVF/ICSI/FET Cycles

Recruiting
NCT02956447Phase 2

Administration of Kisspeptin in Patients With Hyperprolactinemia

Completed
NCT01952782Phase 1

Neuropeptides in Human Reproduction

Completed
NCT00914823Phase 1

Kisspeptin Administration in the Adult

Completed
NCT03141671Phase 2

Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Active Not Recruiting
NCT01438034Phase 1

Kisspeptin in the Evaluation of Delayed Puberty

Completed
NCT05773183

Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men

Unknown
NCT01438073Phase 1

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Completed
NCT00383656Phase 2

Pulsatile GnRH in Anovulatory Infertility

Unknown
NCT00386022Phase 2

The Effects of Aging and Estrogen on the Pituitary

Unknown
NCT01894581Not Applicable

Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women

Completed
NCT00586898Phase 2

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15